$BLK
BlackRock, Inc.
CIK:0002012383|SEC Filings
Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions |
6 Months Ended | |
|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Operating activities | ||
| Net income | $ 4,368 | $ 3,180 |
| Adjustments to reconcile net income to net cash provided by/(used in) operating activities: | ||
| Depreciation and amortization | 765 | 411 |
| Noncash lease expense | 86 | 69 |
| Stock-based compensation | 621 | 467 |
| Deferred income tax expense (benefit) | (18) | (78) |
| Change in fair value of contingent consideration | (538) | 172 |
| Other investment gains | (62) | (433) |
| Net (gains) losses within CIPs | (162) | (183) |
| Net (purchases) proceeds within CIPs | (3,107) | (1,984) |
| (Earnings) losses from equity method investees | (147) | (93) |
| Distributions of earnings from equity method investees | 42 | 147 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | (333) | 114 |
| Investments, trading | 190 | 78 |
| Other assets | (1,718) | (2,480) |
| Accrued compensation and benefits | (1,411) | (1,186) |
| Accounts payable and accrued liabilities | 256 | 182 |
| Other liabilities | 1,415 | 1,853 |
| Net cash provided by/(used in) operating activities | 247 | 236 |
| Investing activities | ||
| Purchases of investments | (753) | (434) |
| Proceeds from sales and maturities of investments | 183 | 230 |
| Distributions of capital from equity method investees | 114 | 262 |
| Net consolidations (deconsolidations) of sponsored investment funds | (54) | (68) |
| Acquisitions, net of cash acquired | (15) | (3,106) |
| Purchases of property and equipment | (215) | (167) |
| Net cash provided by/(used in) investing activities | (740) | (3,283) |
| Financing activities | ||
| Repayments of long-term borrowings | 0 | (796) |
| Proceeds from long-term borrowings | 0 | 1,080 |
| Dividends/Subco distributions paid | (1,906) | (1,646) |
| Proceeds from stock options exercised | 88 | 98 |
| Shares/Subco Units repurchased | (1,271) | (1,053) |
| Net proceeds from (repayments of) borrowings by CIPs | 132 | (29) |
| Net subscriptions received/(redemptions/distributions paid) from noncontrolling interest holders | 2,536 | 1,716 |
| Other financing activities | 0 | (5) |
| Net cash provided by/(used in) financing activities | (421) | (635) |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | (62) | 398 |
| Net increase/(decrease) in cash, cash equivalents and restricted cash | (976) | (3,284) |
| Cash, cash equivalents and restricted cash, beginning of period | 11,490 | 12,779 |
| Cash, cash equivalents and restricted cash, end of period | 10,514 | 9,495 |
| Supplemental schedule of noncash investing and financing transactions: | ||
| Issuance of common shares related to employee stock transactions | 867 | 42 |
| Increase (decrease) in noncontrolling interests due to net consolidation (deconsolidation) of sponsored investment funds | $ (1,341) | $ (1,192) |
Condensed Consolidated Statements of Financial Condition - USD ($) $ in Millions |
Jun. 30, 2026 |
Dec. 31, 2025 |
||||||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash and cash equivalents | [1] | $ 10,492 | $ 11,468 | |||||
| Accounts receivable | 5,444 | 5,158 | ||||||
| Investments | [1] | 15,144 | 13,271 | |||||
| Separate account assets | 65,267 | 60,098 | ||||||
| Separate account collateral held under securities lending agreements | 6,269 | 7,922 | ||||||
| Property and equipment (net of accumulated depreciation and amortization of $1,852 and $1,692 at June 30, 2026 and December 31, 2025, respectively) | 1,305 | 1,256 | ||||||
| Intangible assets (net of accumulated amortization of $1,989 and $1,482 at June 30, 2026 and December 31, 2025, respectively) | 27,415 | 27,968 | ||||||
| Goodwill | 35,203 | 35,283 | ||||||
| Operating lease right-of-use assets | 1,848 | 1,874 | ||||||
| Other assets | [1] | 7,488 | 5,700 | |||||
| Total assets | 175,875 | 169,998 | ||||||
| Liabilities | ||||||||
| Accrued compensation and benefits | 2,432 | 3,830 | ||||||
| Accounts payable and accrued liabilities | 2,012 | 1,740 | ||||||
| Borrowings | 12,744 | 12,768 | ||||||
| Separate account liabilities | 65,267 | 60,098 | ||||||
| Separate account collateral liabilities under securities lending agreements | 6,269 | 7,922 | ||||||
| Contingent consideration liabilities | 7,875 | 8,429 | ||||||
| Deferred income tax liabilities | 4,488 | 4,618 | ||||||
| Operating lease liabilities | 2,224 | 2,228 | ||||||
| Other liabilities | [1] | 8,024 | 6,823 | |||||
| Total liabilities | 111,335 | 108,456 | ||||||
| Commitments and contingencies (Note 15) | ||||||||
| Permanent equity | ||||||||
| Common stock, $0.01 par value;Shares authorized: 500,000,000 at June 30, 2026 and December 31, 2025; Shares issued: 156,276,289 at both June 30, 2026 and December 31, 2025, Shares outstanding: 154,996,807and 155,069,171 at June 30, 2026 and December 31, 2025, respectively | 2 | 2 | ||||||
| Additional paid-in capital | 19,414 | 19,748 | ||||||
| Retained earnings | 40,205 | 37,899 | ||||||
| Accumulated other comprehensive loss | (653) | (545) | ||||||
| Treasury stock, common, at cost (1,279,482 and 1,207,118 shares held at June 30, 2026 and December 31, 2025, respectively) | (1,355) | (1,216) | ||||||
| Total BlackRock, Inc. stockholders’ equity | 57,613 | 55,888 | ||||||
| Nonredeemable NCI - CIPs | 227 | 227 | ||||||
| Total permanent equity | 57,840 | 56,115 | ||||||
| Total liabilities, temporary equity and permanent equity | 175,875 | 169,998 | ||||||
| Subco [Member] | ||||||||
| Temporary equity | ||||||||
| Redeemable noncontrolling interests | 2,828 | 2,791 | ||||||
| Consolidated Sponsored Investment Products [Member] | ||||||||
| Assets | ||||||||
| Cash and cash equivalents | [2] | 335 | 461 | |||||
| Investments | 10,525 | 9,131 | ||||||
| Other assets | 55 | 187 | ||||||
| Liabilities | ||||||||
| Other liabilities | [3] | 4,002 | 4,112 | |||||
| Temporary equity | ||||||||
| Redeemable noncontrolling interests | 3,872 | 2,636 | ||||||
| Permanent equity | ||||||||
| Nonredeemable NCI - CIPs | $ 4,000 | $ 2,757 | ||||||
| ||||||||